Samples with a PD-L1 IHC CPS ≥ 1 had lower DCR (44%) than OncoPrism-HNSCC predicted non-progressors (65%; p = 0.02; compare Table S3 to Fig. 3A). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.